Envisionit DeepAI Ltd

Envisionit DeepAI Ltd

Medical Imaging & Radiology

About Envisionit DeepAI Ltd

Envisionit Deep AI is a UK-based health AI company that addresses critical gaps in medical AI validation and monitoring through its flagship product, RATIFY. The company was founded by Dr. Jaishree Naidoo, a radiologist who recognized that while AI tools performed well in trials, they often behaved unpredictably once deployed in real-world clinical settings. RATIFY is an independent, vendor-agnostic AI assurance platform specifically designed for radiology that provides real-time validation, continuous performance monitoring, drift detection, and human-AI interaction tracking. The platform integrates directly into existing PACS/RIS workflows, operating autonomously in the background without requiring additional clicks from clinicians. By delivering transparent, accountable, and measurable AI performance data, RATIFY helps healthcare providers reduce medico-legal risk from AI misdiagnosis, demonstrate clear ROI on AI investments, eliminate manual quality assurance burdens, and gain insight into bias and model drift. The company's vision is to set the global standard for independent monitoring and assurance of medical AI, ensuring every patient benefits from AI they can trust. Envisionit Deep AI serves hospitals, health systems, and radiology departments seeking to deploy AI tools safely and effectively while maintaining full compliance with EU and FDA standards.

Mission & Story

Mission

To ensure every patient benefits from medical AI they can trust.

Founding Story

Dr. Jaishree Naidoo, a radiologist working in under-resourced South African hospitals, witnessed the urgent need for AI to scale radiological expertise. However, after developing and deploying early AI tools for tuberculosis and pneumonia detection in chest X-rays, she discovered a critical problem: no one was rigorously proving these algorithms were safe or effective for actual patients. Early deployments revealed silent failures and edge cases where AI confidence masked real errors. This realization inspired the company's pivot from developing AI diagnostic tools to building RATIFY, an independent assurance platform that makes AI trust measurable through real-time error detection, rigorous validation, and full regulatory compliance.

Clinical Focus

Medical conditions and clinical areas addressed by Envisionit DeepAI Ltd.

TuberculosisPneumoniaGeneral radiology imaging conditions

Who It Serves

Health SystemsHospitalsRadiology DepartmentsHealthcare Providers

Milestones & Awards

Recent Milestones

Featured on Nasdaq (September 2024); Featured on CNN (August 2024); Keynote speaker at ECR 2025 Vienna (March 2025); Partnership with Bayer announced at RSNA 2024; Sifted Summit London speaker (October 2024); Received Transformative Tech grant from Innovate UK; Expanding RATIFY into other medical imaging modalities; Raising capital for global market reach

Awards & Recognition

Transformative Tech grant from Innovate UK; Featured on Nasdaq; Featured on CNN; Keynote speaker at ECR 2025; Contributing expert to 2024 CLAIM guidelines update for AI in medical imaging

Key Partnerships

Bayer (collaboration announced at RSNA 2024)UK-South African Tech HubInnovate UK

Company Details

Founded
2020
Headquarters
Cobham, Surrey, United Kingdom
Employees
1-10

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing
Last updated Jun 29, 2026

Similar Companies in this Market

View all 189
A2z Radiology Ai

A2z Radiology Ai

AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.

Adas3D Medical S.L

Adas3D Medical S.L

11-50 employees

Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.

AEYE Health

AEYE Health

11-50 employees

AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.

Agfa HealthCare N.V.

Agfa HealthCare N.V.

AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.

AI4MedImaging Medical Solutions

AI4MedImaging Medical Solutions

AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.

Aidence

Aidence

Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.

Aidoc

Aidoc

growth · 350 employees

Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.

Aikenist Technologies Pvt Ltd

Aikenist Technologies Pvt Ltd

21-100 employees

Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.